These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22917248)

  • 21. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides.
    Dathe M; Nikolenko H; Klose J; Bienert M
    Biochemistry; 2004 Jul; 43(28):9140-50. PubMed ID: 15248771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible scaling of dihedral angle barriers during molecular dynamics to improve structure prediction of cyclic peptides.
    Riemann RN; Zacharias M
    J Pept Res; 2004 Apr; 63(4):354-64. PubMed ID: 15102053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
    Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
    J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies.
    Jing X; Jin K
    Med Res Rev; 2020 Mar; 40(2):753-810. PubMed ID: 31599007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
    Clark RJ; Craik DJ
    Biopolymers; 2010; 94(4):414-22. PubMed ID: 20593458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial discovery of tumor targeting peptides using phage display.
    Landon LA; Deutscher SL
    J Cell Biochem; 2003 Oct; 90(3):509-17. PubMed ID: 14523985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone.
    Fridkin G; Rahimipour S; Ben-Aroya N; Kapitkovsky A; Di-Segni S; Rosenberg M; Kustanovich I; Koch Y; Gilon C; Fridkin M
    J Pept Sci; 2006 Feb; 12(2):106-15. PubMed ID: 16059965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
    Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
    Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From combinatorial chemistry to cancer-targeting peptides.
    Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
    Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm.
    Ovadia O; Linde Y; Haskell-Luevano C; Dirain ML; Sheynis T; Jelinek R; Gilon C; Hoffman A
    Bioorg Med Chem; 2010 Jan; 18(2):580-9. PubMed ID: 20056544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From nature to creation: Going around in circles, the art of peptide cyclization.
    Zhang RY; Thapa P; Espiritu MJ; Menon V; Bingham JP
    Bioorg Med Chem; 2018 Mar; 26(6):1135-1150. PubMed ID: 29295762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.
    Monroc S; Badosa E; Feliu L; Planas M; Montesinos E; Bardají E
    Peptides; 2006 Nov; 27(11):2567-74. PubMed ID: 16730857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A safety catch linker for Fmoc-based assembly of constrained cyclic peptides.
    Ravn J; Bourne GT; Smythe ML
    J Pept Sci; 2005 Sep; 11(9):572-8. PubMed ID: 15742335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclization of several linear penta- and heptapeptides with different metal ions studied by CD spectroscopy.
    Liu M; Tang YC; Fan KQ; Jiang X; Lai LH; Ye YH
    J Pept Res; 2005 Jan; 65(1):55-64. PubMed ID: 15686535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
    Pak VV; Koo M; Yun L; Kwon DY
    J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides.
    Williams TM; Sable R; Singh S; Vicente MGH; Jois SD
    Chem Biol Drug Des; 2018 Feb; 91(2):605-619. PubMed ID: 29052959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.